HF-ACTION Risk Calculator
Primary Endpoint Risk Score
Enter baseline CPX duration, KCCQ symptom stability, serum BUN, and sex to calculate the published simplified score.
About the HF-ACTION score
The HF-ACTION predictive score was developed in 2,331 ambulatory patients with chronic systolic heart failure (NYHA class II–IV and LVEF ≤35%) followed for a median of 2.5 years. The primary endpoint was all-cause death or all-cause hospitalization.
This calculator implements the paper's simplified point score for the primary composite endpoint. It does not implement the separate all-cause mortality score.
Score components
| Variable | Published points |
|---|---|
| CPX duration | 65 − (2.2 × duration in minutes) |
| KCCQ: worse | 15 |
| KCCQ: no change/no symptoms | 0 |
| KCCQ: better | 8 |
| BUN 0–19 / 20–39 / 40–59 / 60–79 / ≥80 mg/dL | 0 / 3 / 7 / 10 / 14 |
| Male sex | 6 |
Expected 1-year event risk by score interval
| Score | Decile | Expected risk |
|---|---|---|
| 0–38 | 1 | 21.4% |
| 39–43 | 2 | 28.5% |
| 44–47 | 3 | 32.7% |
| 48–49 | 4 | 35.9% |
| 50–52 | 5 | 39.1% |
| 53–55 | 6 | 42.3% |
| 56–58 | 7 | 46.1% |
| 59–62 | 8 | 50.5% |
| 63–67 | 9 | 56.4% |
| 68–100 | 10 | 68.0% |
References
Clinical use and limitations
- Derived from ambulatory patients with HFrEF and NYHA class II–IV; do not assume validity in acute decompensated HF or HFpEF.
- The score's risk estimates reflect the original study cohort and are not a substitute for contemporary clinical assessment.
- External validation in an independent cohort was not reported in the original publication.
Clinical notes
Document key findings and keep a structured record for your own reference.
My notes
Review, edit, or remove notes saved in this browser.
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.